Infliximab: all 244 studies that test it

Page 1 of 3. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.

• Infliximab for Immune Checkpoint Inhibitor Associated AKIRecruitingNCT07683975Phase 4
• Safety and Efficacy of Topical Infliximab in Autoimmune Dry Eye DiseaseNot yet recruitingNCT07671222Phase 2
• Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory MyelomaRecruitingNCT07657312Phase 2
• Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained RemissionRecruitingNCT07491913Not applicable
• Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's DiseaseNot yet recruitingNCT07417696Phase 4
• Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingNCT07352566Phase 4
• Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO TrialNot yet recruitingNCT07297069Phase 2
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
• Pragmatic, Open-Label Study to Pilot Evaluation for Clinical Trials in Relapsing PolychondritisRecruitingNCT06941376Phase 2
• PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel DiseaseRecruitingNCT06758024Not applicable
• Vedolizumab in Pediatric Ulcerative Colitis- Comparison With InfliximabNot yet recruitingNCT06614387Phase 3
• Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative ColitisRecruitingNCT06453317Phase 2
• Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via InfliximabRecruitingNCT06136546Phase 2
• Subcutaneous Infliximab After A Previous Intravenous Dose OptimizationRecruitingNCT06113913Phase 4
• Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CDRecruitingNCT06064864Not applicable
• Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced ColitisRecruitingNCT05947669Phase 3
• Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease PatientsRecruitingNCT05906576Phase 4
• Anti-Inflammatory Challenge in SchizophreniaRecruitingNCT05823532Phase 4
• Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's DiseaseNot yet recruitingNCT05584228Not applicable
• Pharmacokinetic Infliximab Data in Pediatric Crohn's DiseaseRecruitingNCT05552287Phase 4
• Early Proactive Therapeutic Drug Monitoring of Infliximab in Children: EPIC StudyRecruitingNCT05280405Phase 4
• SOLIDARITY Finland Plus Long-COVIDRecruitingNCT05220280Phase 4
• Topical Infliximab in Eyes With Penetrating KeratoplastyRecruitingNCT05180994Phase 1/2
• Top Down Versus Step up in Pediatric Ulcerative ColitisRecruitingNCT04999228Phase 4
• De-escalation of Anti-TNF Therapy in Inflammatory Bowel DiseaseEnrolling by invitationNCT04646187Phase 4
• Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic ArthritisRecruitingNCT04610476Phase 3
• Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerRecruitingNCT03819296Phase 1
• Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)RecruitingNCT03684278Phase 2
• Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseRecruitingNCT03414502Phase 3
• Infliximab Therapy for Dolichoectactic Vertebrobasilar AneurysmsRecruitingNCT02638701Phase 1/2
• Safety of Reduced Infliximab Infusion TimeCompletedNCT05340764Phase 4Results posted
• MIS-C Comparative Effectiveness StudyCompletedNCT04898231Phase 2/3Results posted
• Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory PneumonitisTerminatedNCT04438382Phase 2Results posted
• A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).CompletedNCT04425538Phase 2Results posted
• A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT03596645Phase 3Results posted
• KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)CompletedNCT03065244Phase 3Results posted
• Dynamics of Inflammation and Its Blockade on Motivational Circuitry in DepressionCompletedNCT03006393Phase 4Results posted
• Inflammation-Induced CNS Glutamate Changes in DepressionTerminatedNCT03004443Phase 4Results posted
• A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)CompletedNCT02990806Phase 3Results posted
• Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to InfliximabCompletedNCT02937701Phase 3Results posted
• An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel DiseaseTerminatedNCT02566889Phase 4Results posted
• Effects of Inhibiting Early Inflammation in Kidney Transplant PatientsCompletedNCT02495077Phase 2Results posted
• 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II DepressionCompletedNCT02363738Phase 2Results posted
• Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing SpondylitisCompletedNCT02359903Phase 1Results posted
• Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)CompletedNCT02251041Phase 2Results posted
• A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).CompletedNCT02222493Phase 3Results posted
• Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's DiseaseCompletedNCT02096861Phase 3Results posted
• A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)CompletedNCT01804166Phase 4Results posted
• A Clinical Study of Increased Dose of TA-650 in Patients With PsoriasisCompletedNCT01680159Phase 3Results posted
• Clinical Study of TA-650 in Patients With Refractory Kawasaki DiseaseCompletedNCT01596335Phase 3Results posted
• Clinical Study of TA-650 in Pediatric Patients With Ulcerative ColitisCompletedNCT01585155Phase 3Results posted
• Clinical Study of TA-650 in Pediatric Patients With Crohn's DiseaseCompletedNCT01580670Phase 3Results posted
• Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special LesionsCompletedNCT01532570Phase 3Results posted
• Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host DiseaseTerminatedNCT01485055Phase 2Results posted
• Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's DiseaseTerminatedNCT01438151Not applicableResults posted
• A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)CompletedNCT01313520Phase 2Results posted
• Seronegative Oligoarthritis of the Knee Study (SOKS)TerminatedNCT01216631Phase 2Results posted
• A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of RecurrenceTerminatedNCT01190839Phase 3Results posted
• A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type PsoriasisCompletedNCT01177800Phase 3Results posted
• Treatment Of Knee Osteoarthritis With Intra-Articular InfliximabCompletedNCT01144143Phase 4Results posted
• Sleep and Immunity in Rheumatoid Arthritis : Remicade SubstudyCompletedNCT00948610Not applicableResults posted
• An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid ArthritisCompletedNCT00896168Phase 4Results posted
• Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)CompletedNCT00844805Phase 3Results posted
• Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)TerminatedNCT00833053Phase 3Results posted
• Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)CompletedNCT00805766Phase 3Results posted
• Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel DiseaseCompletedNCT00791557Not applicableResults posted
• Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED)CompletedNCT00778869Phase 4Results posted
• Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki DiseaseCompletedNCT00760435Phase 3Results posted
• Treatment With Infliximab in a Medical Setting (Study P05587)TerminatedNCT00752622Phase 4Results posted
• A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED)CompletedNCT00732875Phase 3Results posted
• RESTART C0168Z05 Rheumatoid Arthritis StudyCompletedNCT00714493Phase 4Results posted
• Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid ArthritisCompletedNCT00691028Phase 3Results posted
• Infliximab for the Prevention of Recurrent Crohn's Disease After SurgeryCompletedNCT00688636Phase 4Results posted
• A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612)CompletedNCT00687401Phase 3Results posted
• A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)CompletedNCT00687362Phase 2Results posted
• Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)TerminatedNCT00686894Phase 4Results posted
• Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED)CompletedNCT00686686Phase 3Results posted
• A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)CompletedNCT00686595Phase 4Results posted
• Safety and Efficacy of Infliximab in Palmoplantar PsoriasisCompletedNCT00629772Phase 3Results posted
• Multi Center Prospective Registry of Infliximab Use for Childhood UveitisCompletedNCT00589628Phase 4Results posted
• Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)TerminatedNCT00537316Phase 3Results posted
• PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to EtanerceptCompletedNCT00527072Phase 3Results posted
• Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)TerminatedNCT00521924Phase 3Results posted
• Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis CCompletedNCT00512278Phase 2Results posted
• A Study of Infliximab for Treatment Resistant Major DepressionCompletedNCT00463580Phase 4Results posted
• Centocor Microarray Study of PatientsCompletedNCT00462072Phase 4Results posted
• Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)CompletedNCT00367237Phase 3Results posted
• Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)TerminatedNCT00358670Phase 3Results posted
• A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative ColitisCompletedNCT00336492Phase 3Results posted
• Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous DiseaseTerminatedNCT00325078Phase 1/2Results posted
• Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular DegenerationCompletedNCT00304954Phase 2Results posted
• Use of Infliximab for the Treatment of Pemphigus VulgarisCompletedNCT00283712Phase 2Results posted
• Infliximab (Remicade) for Patients With Acute Kawasaki DiseaseCompletedNCT00271570Phase 1Results posted
• Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)CompletedNCT00254982Phase 3Results posted
• The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)CompletedNCT00251641Phase 3Results posted
• An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid ArthritisCompletedNCT00207714Phase 2Results posted
• Beryllium Infliximab Study: Clinical Interventional TrialTerminatedNCT00111917Phase 1/2Results posted
• TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.Active, not recruitingNCT07176754Not applicable
• Efficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical TrialActive, not recruitingNCT06591273Phase 1/2
• Efficacy and Safety of Infliximab Biosimilar Remsima in PsoriasisCompletedNCT06043752Phase 4

← Infliximab overview